167 related articles for article (PubMed ID: 21779187)
1. Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases.
Ma Y; Kwon EH; Lee JE; Kim K; Kim HJ; Kim SH
Korean J Lab Med; 2011 Jul; 31(3):154-6. PubMed ID: 21779187
[TBL] [Abstract][Full Text] [Related]
2. Acquired factor X deficiency associated with atypical AL-amyloidosis.
Furuhata M; Doki N; Hishima T; Okamoto T; Koyama T; Kaito S; Oshikawa G; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Intern Med; 2014; 53(16):1841-5. PubMed ID: 25130122
[TBL] [Abstract][Full Text] [Related]
3. [Acquired factor X deficiency developed four years after autologous transplantation in a patient with multiple myeloma associated with systemic AL amyloidosis].
Takemura T; Fukatsu Y; Nagata Y; Asahina A; Yokota D; Hirano I; Yagyu T; Ono T; Katsumi A; Ohnishi K
Rinsho Ketsueki; 2014 May; 55(5):558-62. PubMed ID: 24881922
[TBL] [Abstract][Full Text] [Related]
4. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy.
Choufani EB; Sanchorawala V; Ernst T; Quillen K; Skinner M; Wright DG; Seldin DC
Blood; 2001 Mar; 97(6):1885-7. PubMed ID: 11238135
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.
Enjeti AK; Walsh M; Seldon M
Haemophilia; 2005 Sep; 11(5):535-8. PubMed ID: 16128899
[TBL] [Abstract][Full Text] [Related]
6. [AL amyloidosis-associated factor X deficiency].
Croles FN; Beerenhout CH; Mulder AB; Meijer K; Nijziel MR
Ned Tijdschr Geneeskd; 2014; 158(6):A6678. PubMed ID: 24495369
[TBL] [Abstract][Full Text] [Related]
7. Normalization of plasma factor X levels in amyloidosis after plasma exchange.
Beardell FV; Varma M; Martinez J
Am J Hematol; 1997 Jan; 54(1):68-71. PubMed ID: 8980263
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
[TBL] [Abstract][Full Text] [Related]
9. Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis.
Harrison JS; Frazier SR; McConnell DD; Yasar SJ; Melnyk N; Salaru G
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):342-347. PubMed ID: 27676646
[TBL] [Abstract][Full Text] [Related]
10. Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.
Emori Y; Sakugawa M; Niiya K; Kiguchi T; Kojima K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Tanimoto M; Yamasaki R; Ohara N; Harada M
Blood Coagul Fibrinolysis; 2002 Sep; 13(6):555-9. PubMed ID: 12192308
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency.
Cordes S; Gertz MA; Buadi FK; Lin Y; Lacy MQ; Kapoor P; Kumar SK; McCurdy A; Dispenzieri A; Dingli D; Hayman SR; Hogan WJ; Pruthi RK
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):101-8. PubMed ID: 26218969
[TBL] [Abstract][Full Text] [Related]
12. The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency.
Iwadate D; Hasegawa E; Hoshino J; Hayami N; Sumida K; Yamanouchi M; Sekine A; Kawada M; Hiramatsu R; Suwabe T; Sawa N; Yuasa M; Wake A; Fujii T; Ohashi K; Takaichi K; Ubara Y
Intern Med; 2018 Mar; 57(5):701-706. PubMed ID: 29093408
[TBL] [Abstract][Full Text] [Related]
13. Successful perioperative management of factor X deficiency associated with primary amyloidosis.
Takabe K; Holman PR; Herbst KD; Glass CA; Bouvet M
J Gastrointest Surg; 2004; 8(3):358-62. PubMed ID: 15019934
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.
Breems DA; Sonneveld P; de Man RA; Leebeek FW
Eur J Haematol; 2004 Mar; 72(3):181-5. PubMed ID: 14962236
[TBL] [Abstract][Full Text] [Related]
15. Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis.
Mahmood S; Blundell J; Drebes A; Hawkins PN; Wechalekar AD
Blood; 2014 May; 123(18):2899-900. PubMed ID: 24786460
[No Abstract] [Full Text] [Related]
16. Factor X deficiency and systemic amyloidosis.
Glenner GG
N Engl J Med; 1977 Jul; 297(2):108-9. PubMed ID: 405589
[No Abstract] [Full Text] [Related]
17. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
Adam Z; Matýková M; Krejcí M; Pour L; Kissová J; Slechtová M; Chlupová G; Stavarová Y; Simonides J; Penka M; Mayer J; Hájek R
Vnitr Lek; 2010 Jan; 56(1):67-78. PubMed ID: 20184115
[TBL] [Abstract][Full Text] [Related]
18. Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease.
Patel G; Hari P; Szabo A; Rein L; Kreuziger LB; Chhabra S; Dhakal B; D'Souza A
Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):10-14. PubMed ID: 30879471
[TBL] [Abstract][Full Text] [Related]
19. Association of acquired von Willebrand syndrome with AL amyloidosis.
Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
[TBL] [Abstract][Full Text] [Related]
20. Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis.
Litvak A; Kumar A; Wong RJ; Smith L; Hassou H; Soff G
Am J Hematol; 2014 Dec; 89(12):1153-4. PubMed ID: 25060940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
